Short Interest in Quantum-Si incorporated (NASDAQ:QSIAW) Decreases By 23.3%

Quantum-Si incorporated (NASDAQ:QSIAW) was the target of a significant decrease in short interest during the month of February. As of February 13th, there was short interest totaling 4,313 shares, a decrease of 23.3% from the January 29th total of 5,622 shares. Based on an average daily trading volume, of 11,118 shares, the short-interest ratio is presently 0.4 days. Based on an average daily trading volume, of 11,118 shares, the short-interest ratio is presently 0.4 days.

Quantum-Si Stock Performance

Shares of NASDAQ:QSIAW traded up $0.03 during midday trading on Wednesday, hitting $0.18. The company’s stock had a trading volume of 70,988 shares, compared to its average volume of 12,712. Quantum-Si has a 12-month low of $0.10 and a 12-month high of $1.08. The business’s 50 day simple moving average is $0.17 and its 200 day simple moving average is $0.28.

Quantum-Si Company Profile

Quantum-Si, Inc (NASDAQ: QSIAW) is a life sciences company focused on developing a next-generation protein sequencing platform. The company aims to unlock the proteome by enabling single-molecule protein analysis, a capability that promises to advance drug discovery, diagnostic development and molecular biology research. Quantum-Si’s core technology leverages proprietary semiconductor-based nanopore arrays and optical detection to directly sequence proteins and quantify expression patterns with high sensitivity.

Headquartered in Pleasanton, California, Quantum-Si was founded to address limitations in existing proteomics methods, such as mass spectrometry, which can be time-consuming and less sensitive to low-abundance proteins.